SMAD2 and oral cavity squamous cell carcinoma: Functional experiments in oral squamous cell carcinoma unraveled that overexpression of GDF10, triggered by type III TGF-β receptor via the TGF-β-SMAD2/3 signaling pathway, resulted in appreciable inhibition in cell proliferation, migration and invasion [25].